Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Complexin (cx) I and cx II are synaptic proteins preferentially expressed by inhibitory and excitatory hippocampal neurons respectively. We previously reported decreased hippocampal formation cx mRNA and protein expression in schizophrenia, with a greater loss of cx II than cx I. The present in situ hybridization study was both an attempt at replication, and an extension to include bipolar and unipolar mood disorders, using sections from the Stanley Foundation brain series. In schizophrenia, both mRNAs were decreased in some hippocampal subfields, especially CA4, but were preserved in subiculum. The cx II/cx I mRNA ratio was unchanged. In bipolar disorder, the mRNAs were reduced in CA4, subiculum and parahippocampal gyrus, with the deficit in subiculum being diagnostically specific. No alterations in cx mRNAs were found in major depression. Treatment of rats with antipsychotics (haloperidol or chlorpromazine) for 2 weeks had no effect on hippocampal cx mRNAs. These data replicate the finding of decreased cx I and cx II expression in the hippocampus in schizophrenia and show a similar or greater abnormality in bipolar disorder. Non-replication of the cx II > cx I mRNA loss in schizophrenia means that the hypothesis of a preferential involvement of excitatory connections was not supported. The results extend the emerging evidence that altered circuitry may be a component of the neuroanatomy of both schizophrenia and bipolar mood disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reductions in synapses and synaptic proteins were evident in BD subjects in the hippocampal subiculum/ventral CA1 region (Eastwood and Harrison 2000; Rosoklija et al. 2000)”
From Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression (2008) · cites this paper as Eastwood and Harrison 2000
Citations
Cites
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Self-citationGlial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
(1995) · PubMed · Cited by 1,320
A Unitary Model of Schizophrenia: Bleuler's "Fragmented Phrene" as Schizencephaly
Andreasen, N. C. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.9.781 · Cited by 610
A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives
Benes, F. M., Kwok, E. W., Vincent, S. L., & Todtenkopf, M. S. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00138-3 · Cited by 470
Harrison, P. J., Heath, P. R., Eastwood, S. L., Burnet, P. W. J., McDonald, B., & Pearson, R. C. A. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12102-a · Cited by 342
Self-citationCell biology of the hippocampal formation in schizophrenia
Weinberger, D. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00331-x · Cited by 321
Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness
Honer, W. G., Falkai, P., Chen, C., Arango, V., Mann, J. J., & Dwork, A. J. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00679-4 · Cited by 244
Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia
Eastwood, S. L., Burnet, P. W. J., & Harrison, P. J. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00586-t · Cited by 223
Self-citation
Cited by
Items 101–183 of 183
Proteomic analysis of rat hippocampus exposed to the antidepressant paroxetine
McHugh, P., Rogers, G., Glubb, D., Joyce, P., & Kennedy, M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109102786 · Cited by 25
“Protein detection was by silver-staining. been implicated in the pathophysiology of several psychiatric disorders, including mood disorders (Eastwood and Harrison, 2000a,b; Sawada, et al., 2002; Knable, et al., 2004), suggesting that these disorders are accompanied by altered synaptic properties.”
BackgroundTensor-Based Morphometry and Stereology Reveal Brain Pathology in the Complexin1 Knockout Mouse
Kielar, C., Sawiak, S. J., Negredo, P. N., Tse, D. H. Y., & Morton, A. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032636 · Cited by 25
Narayanan, B., Ethridge, L. E., O'Neil, K. M., Dunn, S. M., Mathew, I. T., Tandon, N., Calhoun, V. D., Ruaño, G., Kocherla, M., Windemuth, A., et al. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13101411 · Cited by 26
Antidepressants differentially affect expression of complexin I and II RNA in rat hippocampus
Zink, M., Rapp, S., Gebicke‐Haerter, P. J., Henn, F. A., & Thome, J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0017-4 · Cited by 24
Behavioral Neurobiology of Bipolar Disorder and its Treatment
Manji, H. K., & Zarate, C. A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/978-3-642-15757-8 · Cited by 23
Complexin2 modulates working memory-related neural activity in patients with schizophrenia
Haß, J., Walton, E., Kirsten, H., Turner, J. A., Wolthusen, R. P. F., Roessner, V., Sponheim, S. R., Holt, D. J., Gollub, R. L., Calhoun, V. D., et al. (2014) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0550-4 · Cited by 23
Clorgyline-mediated reversal of neurological deficits in a Complexin 2 knockout mouse
Glynn, D., Gibson, H. E., Harte, M., Reim, K., Jones, S., Reynolds, G. P., & Morton, A. J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq252 · Cited by 23
Regulation of complexin 1 and complexin 2 in the developing human prefrontal cortex
Salimi, K., Glantz, L. A., Hamer, R. M., German, T. T., Gilmore, J. H., & Jarskog, L. F. (2008) · Synapse · doi:10.1002/syn.20492 · Cited by 20
Studies on serotonergic markers in the human hippocampus: changes in subjects with bipolar disorder
Dean, B., Scarr, E., Pavey, G., & Copolov, D. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00021-6 · Cited by 22
Pathophysiology of Schizophrenia
Falkai, P., Schmitt, A., & Cannon, T. D. (2011) · Wiley eBooks · doi:10.1002/9780470978672.ch2 · Cited by 21
Glynn, D., Reim, K., Brose, N., & Morton, A. J. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.10.017 · Cited by 19
Ramos-Miguel, A., Honer, W. G., Boyda, H. N., Sawada, K., Beasley, C. L., Procyshyn, R. M., & Barr, A. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.022 · Cited by 18
Sun, F., Liu, Z., Yang, J., Fan, Z., & Yang, J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.764932 · Cited by 18
Presentations of depression in bipolar illness
Post, R. M., Denicoff, K. D., Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T. M., Keck, P. E., McElroy, S. L., Kupka, R., Nolen, W. A., et al. (2002) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(02)00039-7 · Cited by 19
Assessing genomic diversity and selective pressures in Bashan cattle by whole-genome sequencing data
Sun, L., Qu, K., Liu, Y., Ma, X., Chen, N., Zhang, J., Huang, B., & Lei, C. (2021) · Animal Biotechnology · doi:10.1080/10495398.2021.1998094 · Cited by 16
Reduced expression of complexins I and II in rats bred for learned helplessness
Zink, M., Vollmayr, B., Gebicke‐Haerter, P. J., Henn, F. A., & Thome, J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.066 · Cited by 15
Perinatal exposure to alcohol reduces the expression of complexins I and II
Zink, M., Araç, G., Frank, S. T., Gass, P., Gebicke‐Haerter, P. J., & Spanagel, R. (2009) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2009.08.001 · Cited by 14
Maternal alterations in the proteome of the medial prefrontal cortex in rat
Völgyi, K., Udvari, E. B., Szabó, É. R., Györffy, B. A., Hunyadi‐Gulyás, É., Medzihradszky, K. F., Juhász, G. D., Kékesi, K. A., & Dobolyi, Á. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.05.013 · Cited by 13
Xu, Y. Y., Zhao, X., Liu, J., Wang, Y., Xiong, L.-L., He, X., & Wang, T. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-019-02337-5 · Cited by 13
Structural organization of the human complexin 2 gene (CPLX2) and aspects of its functional activity
Raevskaya, N. M., Dergunova, L. V., Vladychenskaya, I. P., Stavchansky, V. V., Oborina, M. V., Poltaraus, A. B., & Limborska, S. A. (2005) · Gene · doi:10.1016/j.gene.2005.07.005 · Cited by 13
No association of complexin1 and complexin2 genes with schizophrenia in a Japanese population
Kishi, T., Ikeda, M., Suzuki, T., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Ozaki, N., & Iwata, N. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.12.842 · Cited by 13
Lohoff, F. W., Weller, A. E., Bloch, P. J., Nall, A. H., Ferraro, T. N., & Berrettini, W. H. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0093-9 · Cited by 12
Kuang, L., Gao, W., Wang, L., Guo, Y., Cao, W., Cui, D., Jiao, Q., Qiu, J., Su, L., & Lu, G. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.08.025 · Cited by 11
Proposed multigenic Composite Inheritance in major depression
Raymer, K. A., Waters, R. F., & Price, C. R. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.11.042 · Cited by 9
Neuroimaging and Neuropathological Findings in Bipolar Disorder
Savitz, J. B., & Drevets, W. C. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_68 · Cited by 9
Liu, H., Gao, W., Cao, W., Meng, Q., Xu, L., Kuang, L., Guo, Y., Cui, D., Qiu, J., Jiao, Q., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05012-3 · Cited by 7
Methodological and Stereological Considerations in Postmortem Psychiatric Brain Research
Everall, I., & Harrison, P. J. (2002) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4757-3631-1_3 · Cited by 7
Self-citationPsychosis effect on hippocampal reduction in schizophrenia
Hýža, M., Hüttlová, J., Keřkovský, M., & Kašpárek, T. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.10.008 · Cited by 6
The Role of Astrocytes in the Pathophysiology of Schizophrenia.
Steffek, A. E. (2007) · Deep Blue (University of Michigan) · Cited by 6
Dergunova, L. V., Nm, R., Vladychenskaya, I. P., & Limborska, S. A. (2003) · Molecular Biology · doi:10.1023/a:1023353907095 · Cited by 6
Estudos transcriptômicos no contexto da conectividade perturbada em esquizofrenia
Schmitt, A., Reich‐Erkelenz, D., Gebicke‐Haerter, P. J., & Falkai, P. (2012) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832012005000001 · Cited by 5
Boyajyan, A., Avetyan, D., Hovhannisyan, L. P., & Mkrtchyan, G. (2015) · InTech eBooks · doi:10.5772/60443 · Cited by 5
Brown, J. S. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000890 · Cited by 5
Yang, T., Liu, J., Chen, Q., Deng, Z., Ni, C., Wang, Y., Lan, Y., Jiang, T., Li, S., Jiang, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64717-z · Cited by 4
Quiroz, J. A., Chen, G., Drevets, W. C., Henter, I. D., & Manji, H. K. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.004 · Cited by 5
Stress and remodeling of hippocampal spine synapses
Hajszán, T. (2020) · Vitamins and hormones · doi:10.1016/bs.vh.2020.04.007 · Cited by 4
Neuropathological studies of bipolar disorder
Harrison, P. J. (2000) · Acta Neuropsychiatrica · doi:10.1017/s0924270800035493 · Cited by 4
Self-citationBennett, M. R. (2012) · Springer eBooks · doi:10.1007/978-94-007-5748-6_6 · Cited by 3
Where will insights into hippocampal activity in schizophrenia lead us?
Antonova, E., & Kumari, V. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.145 · Cited by 3
Cong, E., Zhong, Y., Wu, M., Chen, H., Cai, Y., Zheng, L., Wang, Y., Wen, H., Hu, Y., Zhang, H., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1438144 · Cited by 2
Neuroimaging studies of bipolar depression: therapeutic implications
Savitz, J. B., & Drevets, W. C. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8567-5_8 · Cited by 2
The neuropathology of mood disorders
Harrison, P. J., & Gittins, R. (2003) · Cambridge University Press eBooks · doi:10.1017/cbo9780511550072.015 · Cited by 2
Self-citationNeuroimaging Studies of Bipolar Depression: Therapeutic Implications
Savitz, J. B., Morris, H. M., & Drevets, W. C. (2016) · Milestones in drug therapy · doi:10.1007/978-3-319-31689-5_8 · Cited by 2
Dergunova, L. V., Raevskaya, N. M., Vladychenskaya, I. P., Poltaraus, A. B., Климов, Е. А., Udina, I. G., Сулимова, Г. Е., & Limborska, S. A. (2001) · Molecular Biology · doi:10.1023/a:1012361901392 · Cited by 2
Boyajyan, A. S., Stepanyan, A., Avetyan, D., Ghazaryan, H., Atshemyan, S., Zakharyan, R., Pirumyan, K., & Tsakanova, G. (2014) · International Journal of Genetics and Genomics · doi:10.11648/j.ijgg.20140202.12 · Cited by 1
Sanghai, N., Kelley, R., Lao, Y., Madlangsakay, M. I. R., Paul, P., Llanes-Cuesta, M. A., Wang, J.-F., Zahedi, R. P., Kong, J., & Tranmer, G. K. (2026) · Advanced Science · doi:10.1002/advs.76432 · Cited by 1
Bachus, S. E., & Kleinman, J. E. (2002) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4757-3631-1_11 · Cited by 1
Ghose, S., & Tamminga, C. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74351-6_8 · Cited by 1
Klempan, T. A., Muglia, P., & Kennedy, J. L. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511735103.003 · Cited by 1
Chapter 2. Neurobiology Of Bipolar Depression
Swann, A. C. (2006) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615377428.lg02 · Cited by 1
Quantitative Cytoarchitectonic Findings in Postmortem Brain Tissue from Mood Disorder Patients
Rajkowska, G. (2002) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4757-3631-1_17 · Cited by 1
Schmitt, A., Wobrock, T., Gruber, O., & Falkai, P. (2010) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
Synaptic Pathology in Depression
Vollmayr, B., Henn, F. A., & Zink, M. (2006) · Springer eBooks · doi:10.1007/978-0-387-32562-0_29
Proteomics Providing Insights into Major Psychiatric Disorders
Föcking, M., Pennington, K., English, J., Dunn, M. J., & Cotter, D. (2007) · Wiley eBooks · doi:10.1002/9783527622153.ch22
Sourial-Bassillious, N. (2010) · Figshare
Neurobiologische Grundlagen der Schizophrenie: Synaptopathie, gestörte Neurogenese oder beides?
Gruber, O., Falkai, P., & Schmitt, A. (2010) · Nervenheilkunde · doi:10.1055/s-0038-1628763
A genetic analysis of complexin function in neurotransmitter release and synaptic plasticity
Huntwork, S. (2009) · DSpace@MIT (Massachusetts Institute of Technology)
The human circadian timing system in aging, alzheimer's disease and depression
Wu, Y. (2007) · UvA-DARE (University of Amsterdam)
Molecular Abnormalities in Postmortem Brains of Subjects with Mood Disorders
Dowlatshahi, D. D. (2003) · MacSphere (McMaster University) · doi:10.71548/23357
Mediators of synaptic activity in anxiety- and depression-related behaviors
Kiselycznyk, C. (2012) · Figshare
Synaptic Dysfunction in Huntington’s Disease
Glynn, D., & Morton, A. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7061-9_12
Neuroprotective Agents in Mood Disorders: Pathophysiological and Therapeutic Implications
Salvadore, G., Machado‐Vieira, R., & Manji, H. K. (2010) · Springer eBooks · doi:10.1007/978-90-481-8553-5_14
Clark, D. L., Boutros, N. N., & Mendez, M. F. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511776915.013
Lam, C. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0091131
Brain development: the clinical perspective
Beasley, C. L., Williams, B. P., & Everall, I. (2003) · Cambridge University Press eBooks · doi:10.1017/cbo9780511550072.005
The Hypoxic Rat Model for Obstetric Complications in Schizophrenia
Schmitt, A., Gebicke‐Haerter, P. J., Sommer, U. J., Heck, M., Lex, A., Herrera‐Marschitz, M., Zink, M., Fendt, M., & Falkai, P. (2011) · Neuromethods · doi:10.1007/978-1-61779-157-4_4
The Kindling/Sensitization Model: Implications for the Pathophysiology of Bipolar Disorder
Post, R. M. (2007) · Medical psychiatry · doi:10.3109/9781420021158.016
Grube, S. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3163
Kruger, R. (2014) · Boloka Institutional Repository (North-west University)
Woźniak, P. A., Olędzka-Oręziak, M., Poniatowska, R., Motyl, R., & Wardyn, K. A. (2017) · Postępy Psychiatrii i Neurologii · doi:10.5114/ppn.2017.69375
Az anyai magatartás szabályozásában fontos agyterületek proteomikai vizsgálata patkányokon
Udvari, E. B. (2020) · Eötvös Loránd Tudományegyetem · doi:10.15476/elte.2019.073
Bennett, M. R. (2012) · Springer eBooks · doi:10.1007/978-94-007-5748-6_4
Heckers, S. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_9
Potential Linkages between Alzheimer’s Disease and Major Depression
Raudino, F. (2023) · Mustansiriya Medical Journal · doi:10.4103/mj.mj_65_22
Jarskog, L. F., & Woo, T.-U. W. (2020) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379194.lg07
Pathogenic CPLX1 mutations in neurological disorders and malignant epilepsy
Yuan, H. (2025) · New medicine. · doi:10.61958/nmlp8288
Neuroimaging in Psychiatry 2023: Mood Disorders
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-6998-6
Schulz, P. (2025) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.34944
The effects of perinatal hypoxia on hippocampal neurogenesis /
Labban, M. (2006) · doi:10.82308/24880
Perova, T. (2006) · TSpace (University of Toronto)
Takano, T., Nagamoto, S., Ito, Y., Fukuda, A., Matsubayashi, J., Morikawa, S., Onishi, K., Funakosi, M., Soderling, S. H., Takeuchi, H., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8597698/v2
Metadata
- Authors
- Eastwood, S. L., & Harrison, P. J.
- Affiliations
- University of Oxford (GB)
- Corresponding author
- Harrison, P J
- ORCID
- Harrison, P J
- Venue
- Molecular Psychiatry
- Published
- 2000-06-30
- Volume
- 5
- Issue
- 4
- Pages
- 425-432
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2015268580
- Cited by
- 170
- References
- 30
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 5 · 2014: 3 · 2013: 4 · 2012: 11
- FWCI
- 9.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- complexin II, hippocampus, schizophrenia, bipolar disorder, major depressive disorder, synaptic proteins, CA4, subiculum, parahippocampal gyrus, antipsychotic drugs, haloperidol, chlorpromazine, mood disorders, neuroanatomy
- MeSH terms
- Adult, Animals, Bipolar Disorder, Brain Chemistry, Depressive Disorder, Female, Hippocampus, Humans, Male, Middle Aged, Nerve Tissue Proteins, RNA, Messenger, Schizophrenia, Synapses, Antipsychotic Agents, Gene Expression, Rats, Sprague-Dawley, Adaptor Proteins, Vesicular Transport, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.